Coastal Investment Advisors, Inc. Novavax Inc Transaction History

Coastal Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$69.73 - $142.9 $123,770 - $253,647	-1,775 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$134.56 - $217.97 $3,364 - $5,449	-25 Reduced 1.39%	1,775 $254,000
Q4 2020 Jan 13, 2021	SELL	$78.74 - $139.5 $39,370 - $69,750	-500 Reduced 21.74%	1,800 $201,000
Q3 2020 Oct 23, 2020	BUY	$79.44 - $178.51 $182,712 - $410,573	2,300 New	2,300 $249,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.